LuAF21934 is primarily utilized in the field of neuroscience research, particularly in the study of neurodegenerative diseases. It is known for its potential as a therapeutic agent in conditions such as Alzheimer's disease, where it may help in reducing amyloid-beta plaques, a hallmark of the disease. Researchers are investigating its efficacy in improving cognitive functions and slowing disease progression. Additionally, LuAF21934 is being explored for its neuroprotective properties, which could be beneficial in other neurological disorders characterized by neuronal damage. Its application extends to preclinical studies, where it is used to understand the underlying mechanisms of neurodegeneration and to develop novel treatment strategies.